ResearcherCapital Medical UniversityActive in the last 2 years
Chuanlong Zhang
Matched on ORCID iD 0000-0002-8485-5537; OpenAlex author ID A5034134767. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 5
- Pi Ji Pills reshape the pancreatic cancer immune microenvironment and enhance the efficacy of gemcitabine through dual mechanisms of PI3K/AKT pathway blockade … Co-author DOI 10.1016/j.jep.2025.120579↗
- Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase. Co-author DOI 10.1038/s41417-024-00768-6↗
- SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN. Co-author DOI 10.1038/s41598-023-44646-x↗
- Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer. Co-author DOI 10.18632/aging.205048↗
- Emerging current trends and research focus related to pancreatic cancer metabolism: A bibliometric and visualized analysis. First author DOI 10.3389/fonc.2022.1009700↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bo Pang · 5 shared papers, 2022–2026 · strength 1.06
- Paper Pi Ji Pills reshape the pancreatic cancer immune microenvironment and enhance the efficacy of gemcitabine through dual … DOI 10.1016/j.jep.2025.120579↗
- Paper Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase. DOI 10.1038/s41417-024-00768-6↗
- Paper Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic … DOI 10.18632/aging.205048↗
- Qian Shen · 4 shared papers, 2022–2026 · strength 0.86
- Paper Pi Ji Pills reshape the pancreatic cancer immune microenvironment and enhance the efficacy of gemcitabine through dual … DOI 10.1016/j.jep.2025.120579↗
- Paper Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic … DOI 10.18632/aging.205048↗
- Paper SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN. DOI 10.1038/s41598-023-44646-x↗
- Yi Li · 3 shared papers, 2023–2026 · strength 0.70
- Paper Pi Ji Pills reshape the pancreatic cancer immune microenvironment and enhance the efficacy of gemcitabine through dual … DOI 10.1016/j.jep.2025.120579↗
- Paper Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic … DOI 10.18632/aging.205048↗
- Paper SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN. DOI 10.1038/s41598-023-44646-x↗
- Songting Shou · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.